Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome

BACKGROUND: Corticosteroids are widely used in patients with COVID 19, although their benefit-to-risk ratio remains controversial. METHODS: Patients with severe COVID-19–related acute respiratory distress syndrome (ARDS) were included from December 29, 2019 to March 16, 2020 in 5 tertiary Chinese ho...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Invest
Päätekijät: Liu, Jiao, Zhang, Sheng, Dong, Xuan, Li, Zhongyi, Xu, Qianghong, Feng, Huibin, Cai, Jing, Huang, Sisi, Guo, Jun, Zhang, Lidi, Chen, Yizhu, Zhu, Wei, Du, Hangxiang, Liu, Yongan, Wang, Tao, Chen, Limin, Wen, Zhenliang, Annane, Djillali, Qu, Jieming, Chen, Dechang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 2020
Aiheet:
Clinical Medicine
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685724/
https://ncbi.nlm.nih.gov/pubmed/33141117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI140617
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia